Rajiv Radhakrishnan | Psychiatrist.com

Original Research

Antipsychotics for Homeless and Unstably Housed Veterans

Many homeless and unstably housed (HUH) adults have severe mental illness managed with antipsychotic medications. This study examined antipsychotic medication use and correlates of antipsychotic medication prescriptions among HUH...

Original Research

Body Mass Index Identified as an Independent Predictor of Psychiatric Readmission

Article

Medical Marijuana for Psychiatric Indications

Too much of a good thing? As of June 2016, marijuana was legal for medical use in 25 states in the US. Learn what the authors discovered during their...

ASCP Corner

Medical Marijuana: What Physicians Need to Know

As of March 2019, "medical marijuana" has been approved in 33 states; however, these products are not FDA-regulated. This article summarizes the evidence for marijuana in psychiatric indications, as...

Original Research

Elevated Unconjugated Bilirubin in Schizophrenia

Could serum unconjugated bilirubin be a potential marker for schizophrenia? This study compared levels of patients with schizophrenia to those with bipolar disorder. Read on to find out more.

Letter to the Editor

A Case of Amelioration of Venlafaxine-Discontinuation "Brain Shivers" With Atomoxetine

ASCP Corner

Psychedelics and Treatment of Psychiatric Disorders, Part 1: Psychopharmacology and Neurobiological Effects

In addition to altering one’s perception of reality, psychedelics may be useful for treating certain psychiatric disorders. This brief review looks at the mechanisms behind their effects.

ASCP Corner

Psychedelics and Treatment of Psychiatric Disorders, Part 2: Review of the Evidence

Could psychedelics such as psilocybin and LSD be useful in treating MDD or other psychiatric disorders? This brief review looks at the evidence.

Impact of SUD on COVID-19 Outcomes

Original Research

Impact of SUD on COVID-19 Outcomes

Identifying risk factors that predispose individuals to negative COVID-19 outcomes is important. The current study examined the association between substance use disorders, psychiatric diagnosis, and COVID-19–related clinical outcomes.